Literature DB >> 10639038

Infusion versus bolus of an ultrasound contrast agent: in vivo dose-response measurements of BR1.

J M Correas1, P N Burns, X Lai, X Qi.   

Abstract

RATIONALE AND
OBJECTIVES: To determine the efficacy of an ultrasound contrast agent infusion using Doppler intensitometry estimation of backscatter enhancement in blood.
METHODS: Multiple intravenous injections of BR1 (SonoVue) were performed in chronic dog studies, using bolus (0.05-2 mL) and infusion (3-40 mL/h during 6 minutes) administration. The pulsed Doppler signal from the femoral artery was recorded and analyzed for mean Doppler power and integrated fractional enhancement.
RESULTS: For bolus injection, time-intensity curves exhibited a rapid first pass (peak 30 dB for 0.45 mL) followed by a slower washout. Integrated fractional enhancement exhibited a linear relation with the dose (R2 = 0.99). For infusion administration, peak enhancement increased with the infusion rate from 8 to 22 dB. At rates exceeding 30 mL/h, the enhancement was stable with a plateau-like pattern.
CONCLUSIONS: Infusion of BR1 is easily achieved and allows the duration of enhancement to be increased as long as desired. Stable enhancement is obtained for rates greater than 30 mL/h.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639038     DOI: 10.1097/00004424-200001000-00008

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  12 in total

1.  Assessment of tissue perfusion by contrast-enhanced ultrasound.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2010-10-07       Impact factor: 5.315

Review 2.  [Ultrasound contrast agents: substance classes, pharmacokinetics, clinical applications, safety aspects].

Authors:  C Krestan
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 3.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 4.  Microbubble ultrasound contrast agents: an update.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2007-03-10       Impact factor: 5.315

5.  Quantitative analysis of myocardial perfusion in rabbits by transthoracic real-time myocardial contrast echocardiography.

Authors:  Heping Deng; Mingxing Xie; Xinfang Wang; Qing Lv; Songnan Li; Yuting Bao; Jing Wang; Xiaofang Lu; Yali Yang; Bo Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

6.  Estimation of intra-operator variability in perfusion parameter measurements using DCE-US.

Authors:  Marianne Gauthier; Ingrid Leguerney; Jessie Thalmensi; Mohamed Chebil; Sarah Parisot; Pierre Peronneau; Alain Roche; Nathalie Lassau
Journal:  World J Radiol       Date:  2011-03-28

Review 7.  How Can New Imaging Modalities Help in the Practice of Radiology?

Authors:  Berhan Pirimoglu; Recep Sade; Hayri Ogul; Mecit Kantarci; Suat Eren; Akın Levent
Journal:  Eurasian J Med       Date:  2016-10

8.  Contrast-enhanced ultrasonography in clinical practice in Crohn's disease: feasibility of destruction/replenishment method and software analysis.

Authors:  Andrea Giannetti; Marco Matergi; Marco Biscontri; Luca Franci
Journal:  J Ultrasound       Date:  2017-10-31

9.  Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients.

Authors:  Paolo Sorrentino; Salvatore D'Angelo; Luciano Tarantino; Umberto Ferbo; Alessandra Bracigliano; Raffaela Vecchione
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

10.  Predicting Long-Term Hepatocellular Carcinoma Response to Transarterial Radioembolization Using Contrast-Enhanced Ultrasound: Initial Experiences.

Authors:  Lauren J Delaney; Mohamed Tantawi; Corinne E Wessner; Priscilla Machado; Flemming Forsberg; Andrej Lyshchik; Patrick O'Kane; Ji-Bin Liu; Jesse Civan; Allison Tan; Kevin Anton; Colette M Shaw; John R Eisenbrey
Journal:  Ultrasound Med Biol       Date:  2021-06-13       Impact factor: 3.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.